NCT02473757
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
Enrolling by Invitation
Not specifiedAges 18+ObservationalNational Cancer Institute (NCI)Government-funded
~1,000 participants
Updated 2026-08-04 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To provide long term follow up of patients previously enrolled on treatment protocols in the NCI ETIB Branch.
Measured over 15 years
Conditions
Where it's being run
1 sites across 1 statesMaryland1
Study leadership
- James N Kochenderfer, M.D. · PRINCIPAL_INVESTIGATOR · National Cancer Institute (NCI)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Subjects who have received treatment on a CAR T-cell gene therapy protocol. Age \>= 18 years as children are generally excluded from CAR T-cell gene therapy studies.
What this trial measures
- To provide long term follow up of patients previously enrolled on treatment protocols in the NCI ETIB Branch.15 years
List of long time adverse event frequency after Gene therapy drug